Blood pressure and lipid control status in Japanese hypertensive patients.

Clin Exp Hypertens

Division of Hypertension, Clinical Research Institute, National Kyushu Medical Center, Jigyohama 1-8-1, Chuo-ku, Fukuoka 810-8563, Japan.

Published: June 2009

Strict blood pressure (BP) as well as lipid control is important to prevent cardiovascular events. The purpose of this study was to evaluate BP and lipid control status in hypertensive patients. Subjects were a total of 717 hypertensive patients who had been followed at National Kyushu Medical Center in FuKuoka, Japan. Goal BP was defined as < 130/85 mmHg (< 65 years) or < 140/90 mmHg (> or = 65 years). According to the Japanese guidelines, goal LDL cholesterol (LDL-C) levels were defined based on the patient category. Average BP level and the number of anti-hypertensive drugs were 133 + or - 12/74 + or - 9 mmHg and 2.1 + or - 1.1, respectively, and the LDL-C level was 119 + or - 27 mg/dl. Goal BP was achieved in 40% of the patients of < 65 years and 67% of the elderly patients. Goal LDL-C was achieved in 65% of the patients. Even in the patients taking lipid-lowering agents (n = 178), 30% failed to achieve goal LDL-C levels. In the patients who achieved BP < 130/85 mmHg, 67% also achieved goal LDL-C, whereas 61% of the patients whose BP > or = 140/90 mmHg achieved goal LDL-C. Both goal BP and LDL-C were achieved in 39% of the male and 36% of the female patients. In contrast, neither goal BP nor goal LDL-C was achieved in 16% of the male and 17% of the female patients. Results suggest that intensive intervention should be required to achieve satisfactory BP and lipid control in hypertensive patients.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10641960802621317DOI Listing

Publication Analysis

Top Keywords

goal ldl-c
24
lipid control
16
hypertensive patients
16
patients
12
ldl-c achieved
12
goal
10
blood pressure
8
control status
8
130/85 mmhg
8
mmhg years
8

Similar Publications

Importance: Medication adherence is important for managing blood pressure (BP), low-density lipoprotein cholesterol (LDL-C), and hemoglobin A1c (HbA1c). Interventions to improve medication adherence are needed.

Objective: To examine the effectiveness of an intervention using algorithmic identification of low medication adherence, clinical decision support to physicians, and pharmacist outreach to patients to improve cardiometabolic medication adherence and BP, LDL-C, and HbA1c control.

View Article and Find Full Text PDF

PCSK9 Inhibitors: Focus on Evolocumab and Its Impact on Atherosclerosis Progression.

Pharmaceuticals (Basel)

November 2024

Department of Pharmacology and Toxicology, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.

This paper investigates the therapeutic use of PCSK9 inhibitors, particularly Evolocumab, as monoclonal antibodies for the treatment of atherosclerosis based on recent literature reviews. PCSK9 is an outstanding example of a breakthrough in medical science, with advancements in understanding its biological function driving substantial progress in atherosclerosis treatment. Atherosclerotic cardiovascular disease (ASCVD) is a leading global cause of mortality, imposing substantial financial burdens on healthcare systems.

View Article and Find Full Text PDF

: Low-density lipoprotein cholesterol (LDL-C) is a marker of cardiovascular risk and its management. This study evaluated LDL-C control trends in patients treated at a primary healthcare center in Lithuania. : Five-year (2019-2023) data on patients aged 40 years or older diagnosed with dyslipidemia were extracted from a real-world data and analytics platform, TriNetX.

View Article and Find Full Text PDF
Article Synopsis
  • Metabolic syndrome (MetS) encompasses a group of risk factors including dysglycemia, hyperinsulinemia, and hypertension, with diet playing a crucial role in its prevention and management.
  • In a study involving 338 obese participants, dietary intake was assessed to calculate the nutrient adequacy ratio (NAR) for vitamins and minerals, while various metabolic factors were measured using biochemical tests.
  • Results indicated that higher NAR correlates with increased fat-free mass and greater overall nutrient intake, but there was no significant relationship between NAR and metabolic profiles or glycemic status.
View Article and Find Full Text PDF

Association between remnant cholesterol (RC) and endometriosis: a cross-sectional study based on NHANES data.

Lipids Health Dis

January 2025

Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.

Background: Prior research indicates a potential link between dyslipidemia and endometriosis (EMs). However, the relationship between remnant cholesterol (RC) and EMs has not been thoroughly investigated. Consequently, looking into and clarifying the connection between RC and EMs was the primary goal of this study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!